Hillsdale Investment Management’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-151,951
Closed -$4.21M 668
2024
Q1
$4.21M Buy
+151,951
New +$3.37M 0.33% 113
2021
Q4
Sell
-119,500
Closed -$3.74M 602
2021
Q3
$3.74M Sell
119,500
-30,200
-20% -$1.19M 0.29% 124
2021
Q2
$6.34M Sell
149,700
-6,350
-4% -$247K 0.5% 40
2021
Q1
$5.87M Sell
156,050
-3,000
-2% -$93.8K 0.49% 53
2020
Q4
$4.3M Buy
+159,050
New +$4.09M 0.41% 75

Other funds holding ACH

Hillsdale Investment Management's ACH Position: Q2 2024 in Review

Hillsdale Investment Management sold out of Accendra Health (ACH) in Q2 2024, closing a stake of 151,951 shares — an estimated $4.21M sold.

Hillsdale Investment Management first reported a position in ACH in Q4 2020 and held it in 5 quarters. The position peaked at $6.34M in Q2 2021. 221 funds tracked by Wall St. Rank hold ACH as of Q2 2024.

  • Hillsdale Investment Management reported no remaining Accendra Health position as of Q2 2024 after selling out during the quarter.
  • Hillsdale Investment Management sold 151,951 Accendra Health shares in Q2 2024, an estimated $4.21M.
  • Hillsdale Investment Management first reported a position in Accendra Health in Q4 2020 and held it in 5 quarters.
  • Hillsdale Investment Management's Accendra Health position peaked at $6.34M in Q2 2021.
  • 221 funds tracked by Wall St. Rank held Accendra Health as of Q2 2024.

Based on Hillsdale Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.